Com base no cpa 2025_1303 - Glofitamab - justificação clinica
TED · 631171-2026Award noticeawardedNo deadline given
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde de Coimbra, EPE in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Brainlab Sales GmbH | 1 | €1,899,000 | 2026-06-19 |
| Takeda Farmacêuticos Portugal, Lda | 1 | €1,828,250 | 2026-07-17 |
| Cencora 3PL Portugal, S.A. | 1 | €1,435,097 | 2026-07-20 |
| Getinge Group Portuga, Unipessoal, Lda. | Iberdata Equipamentos, SA | 1 | €1,412,619 | 2026-05-21 |
| LUSOPALEX PRODUTOS DE SAUDE UNIPESSOAL, LDA | SOCIME II - PRODUTOS MEDICOS, LDA | 1 | €956,400 | 2026-09-09 |
Full buyer profile: what Unidade Local de Saúde de Coimbra, EPE buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Aquisição de Glofitamab 2.5 MG/2.5 ML SOL INJ FR 2.5 ML IV e Glofitamab 10 MG/10 ML SOL INJ FR 10 ML IV
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-08-17 | C/ BASE NO CPA 2024_900 - LAMIVUDINA 300 MG + DOLUTEGRAVIR 50 MG COMP | Unidade Local de Saúde de Coimbra, EPE PT | 93% |
| 2026-08-04 | 2025/1746 - EMICIZUMAB [150 MG/ML 0,4 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |
| 2026-09-09 | C/ base no CPA 2023_368 - cloro-hexidina 0.2% gel bucal bisn 40 ml | Unidade Local de Saúde de Coimbra, EPE PT | 93% |
| 2026-06-09 | 2025/1746 -EMICIZUMAB [150 MG/ML 0,4 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |
| 2026-08-12 | Aquisição de TISLELIZUMAB 10 MGML SOL INJ FR 10 ML IV 2026 - NOVO | Unidade Local de Saúde de Gaia/Espinho, EPE PT | 93% |
| 2026-07-20 | Maralixibat 9.5 Mg/mL Sol Oral Fr 30 mL | Unidade Local de Saúde de Coimbra, EPE PT | 93% |